- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- May 2025
- 210 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- June 2025
- 77 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 274 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 384 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 185 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 273 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 267 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- November 2024
- 313 Pages
Global
From €4478EUR$5,000USD£3,818GBP
- Report
- July 2024
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2025
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- December 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP

The Neurotech market is a subset of the Neurology Devices industry, focusing on the development and commercialization of products and services related to the diagnosis, treatment, and management of neurological disorders. Neurotech products range from medical devices such as brain-computer interfaces, deep brain stimulation systems, and neuroprosthetics, to software and digital health solutions such as brain-computer interfaces, virtual reality, and artificial intelligence. Neurotech companies are also developing novel treatments for neurological disorders, such as gene therapy, stem cell therapy, and gene editing.
The Neurotech market is driven by advances in technology, increasing prevalence of neurological disorders, and growing demand for personalized treatments. Neurotech companies are also leveraging the power of data to develop more effective treatments and improve patient outcomes.
Notable companies in the Neurotech market include NeuroPace, NeuroMetrix, BrainScope, NeuroSigma, NeuroVista, and NeuroSens. Show Less Read more